Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 75 of 75 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/05/22
End: 09/30/27
Due: 09/30/28
Phase: N/A
Priority: Normal
Start: 04/30/01
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 09/30/15
End: 10/11/18
Due: 10/11/19
Phase: N/A
Priority: Normal
Start: 02/29/16
End: 07/09/18
Due: 07/09/19
Phase: N/A
Priority: Normal
Start: 10/31/00
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 09/30/03
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 11/30/03
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 01/31/00
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 06/30/02
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 11/30/03
End: -
Due: -
Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase: N/A
Priority: Normal
Start: 04/30/99
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 06/30/08
End: 06/30/12
Due: 06/30/13
Phase: N/A
Priority: Normal
Start: 05/20/20
End: 11/30/24
Due: 11/30/25
Phase: N/A
Priority: Normal
Start: 10/31/07
End: 12/31/12
Due: 12/31/13
Phase: N/A
Priority: Normal
Start: 05/31/11
End: 12/31/14
Due: 12/31/15
Phase: N/A
Priority: Normal
Start: 09/30/25
End: 12/31/29
Due: 12/31/30
Phase: N/A
Priority: Normal
Start: 07/31/19
End: 12/30/24
Due: 12/30/25
Phase: N/A
Priority: Normal
Start: 01/31/99
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 02/29/08
End: 09/30/14
Due: 09/30/15
Phase: N/A
Priority: Normal
Start: 08/31/05
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 09/23/15
End: 01/31/17
Due: 01/31/18
Phase: N/A
Priority: Normal
Start: 01/01/03
End: 12/31/31
Due: 12/31/32
Phase: N/A
Priority: Normal
Start: 05/31/04
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 07/13/17
End: 07/15/19
Due: 07/15/20
Phase: N/A
Priority: Normal
Start: 07/31/02
End: -
Due: -